- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Titan Biotech Limited has completed the sub-division of its equity shares. Following a previous announcement, one equity share with a face value of Rs. 10 has been split into five equity shares, each with a face value of Rs. 2. The new sub-divided shares have been successfully credited to investor accounts under the new ISIN INE150C01029 by both NSDL and CDSL. This corporate action aims to enhance liquidity and accessibility of the company's shares in the market for retail investors.